Cvs Health Maximum Strength

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the relief of symptoms associated with acid indigestion, heartburn, sour stomach, and upset stomach. It is also effective in alleviating bloating and pressure commonly referred to as gas.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children 12 years and older are advised to chew 1 to 2 tablets as symptoms occur or as directed by a healthcare professional. It is important not to exceed a maximum dosage of 8 tablets within a 24-hour period. Additionally, the maximum dosage should not be used for more than 2 weeks unless under the guidance and supervision of a healthcare provider.

Contraindications

There are no specific contraindications listed for this product. However, it is advised to discontinue use and consult a healthcare professional if symptoms persist for more than two weeks.

Warnings and Precautions

Patients should not exceed a maximum dosage of 8 tablets within a 24-hour period or utilize the maximum dosage for longer than 2 weeks without the guidance and supervision of a healthcare professional.

Prior to use, individuals should consult a physician if they have a history of kidney stones or are on a calcium-restricted diet, as these conditions may influence the safety and efficacy of the treatment.

It is also advisable for patients to seek counsel from a healthcare provider or pharmacist if they are currently taking any prescription medications. Antacids have the potential to interact with certain prescription drugs, which may necessitate adjustments in therapy or monitoring.

Should symptoms persist beyond a duration of 2 weeks, it is imperative to discontinue use and consult a healthcare professional for further evaluation and management.

Side Effects

Patients using this product may experience adverse reactions, with constipation being a notable side effect, particularly at the maximum recommended dose.

In the event that symptoms persist for more than two weeks, patients are advised to discontinue use and consult a healthcare professional for further evaluation and guidance.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Cvs Health Maximum Strength (antacid and antigas). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 12 years and older may chew 1 to 2 tablets as symptoms occur or as directed by a healthcare professional. The maximum dosage should not exceed 8 tablets in a 24-hour period, and the maximum dosage should not be used for more than 2 weeks unless advised and supervised by a healthcare provider. It is important to keep this medication out of reach of children.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

The product has not been specifically evaluated for use during pregnancy. Therefore, healthcare professionals are advised to consult a doctor before recommending this product to pregnant patients or those planning to become pregnant. Currently, there are no specific dosage modifications provided for pregnant individuals. Additionally, there are no explicit warnings or contraindications listed regarding the use of this product during pregnancy. As such, the potential risks and benefits should be carefully considered in the context of individual patient circumstances.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there are no specific warnings or recommendations related to lactation in the provided information. Therefore, healthcare professionals may consider the use of this product in nursing mothers on a case-by-case basis, taking into account the individual circumstances and needs of the mother and infant.

Renal Impairment

Patients with renal impairment should consult a healthcare professional prior to use if they have kidney stones or are on a calcium-restricted diet. It is essential to evaluate the potential impact of reduced kidney function on treatment decisions and to ensure appropriate management of any related conditions.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary significantly depending on the substance involved and the individual patient’s characteristics. Symptoms may include, but are not limited to, altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate assessment of the patient's condition is crucial. Recommended actions include:

1. Assessment: Conduct a thorough evaluation of the patient's vital signs and clinical status.

2. Supportive Care: Initiate supportive measures as necessary, including airway management, oxygen supplementation, and intravenous fluids.

3. Decontamination: If appropriate and within a reasonable timeframe, consider gastrointestinal decontamination methods such as activated charcoal, provided the patient is alert and able to protect their airway.

4. Specific Antidotes: If a specific antidote is available for the substance involved, it should be administered according to established protocols.

Healthcare professionals are encouraged to consult local poison control centers or toxicology experts for guidance on management strategies tailored to the specific circumstances of the overdose. Continuous monitoring and supportive care are paramount until the patient stabilizes or further interventions are deemed necessary.

Documentation of the incident, including the substance involved, estimated dose, time of ingestion, and any interventions performed, is critical for ongoing patient management and future reference.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. Patients should be informed to discontinue use and consult a doctor if their symptoms persist for more than two weeks, as this may indicate a need for further evaluation.

When discussing the use of this product, healthcare providers should highlight that using it at the maximum recommended dose may lead to constipation. It is also important for patients to seek medical advice before using this product if they have a history of kidney stones or if they are on a calcium-restricted diet, as these conditions may affect the safety and efficacy of the product.

Additionally, healthcare providers should recommend that patients consult with their doctor or pharmacist prior to use if they are currently taking any prescription medications. This is crucial, as antacids may interact with certain prescription drugs, potentially leading to adverse effects or reduced effectiveness of the medications.

Storage and Handling

The product is supplied in a configuration that ensures optimal integrity and efficacy. It should be stored at a temperature range of 20-25°C (68-77°F) to maintain its quality. It is essential to keep the container tightly closed and in a dry environment to prevent any degradation. Freezing must be avoided, as it can compromise the product's stability. Additionally, the product should not be used if the printed inner seal is broken or missing, as this indicates potential tampering or contamination.

Additional Clinical Information

The medication is administered orally. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Cvs Health Maximum Strength, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)